- BioHarvest Sciences press release (NASDAQ:BHST): Q1 GAAP EPS of -$0.13 misses by $0.01.
- Revenue of $7.9M (+49.1% Y/Y) beats by $0.1M.
- Management expects Q2 2025 revenues of at least $8.5M and expects to reach adjusted EBITDA breakeven in the second half of 2025.